Mesoblast (MSB) is still some years off FDA approval for its...

Mesoblast (MSB) is still some years off FDA approval for its various stem cell techniques for use on humans, including its orthopedics. SP = $7.80 Market Cap = $2.2b

MLA's stem cell technology for use on animals is available here and now. They have just announced their cryo bank in the UK and are able to effectively provide a one-stop-shop to vets. SP = 1.9 cents Market Cap = $8.6m

MLA market cap is under 0.4% of Mesoblast (i.e. MSB = 255 times the market cap of MLA).

On the stem cell opportunity alone and given the excitement, interest and promise in this area (and allowing for the fact that MSB's technology still has to pass FDA approval in 2-3 years time) and even allowing for the fact that it is an apples versus oranges comparison, I think there is is plenty of upside for MLA.

Between pet and racehorse treatment, this is all very exciting - we all know how much money is spent by pet/horse owners on treatments.